Aarti Pharmalabs Limited (AARTIPHARM.NS) NSE
635.20
-7.15(-1.11%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 57.58B |
| Enterprise Value | 65.02B |
| P/E Ratio | 30.89 |
| PEG Ratio | -0.98 |
| Price/Sales Ratio | 3.17 |
| Price/Book Ratio | 2.71 |
| Enterprise/Revenue | 3.57 |
| Enterprise/EBITDA | 16.23 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.16 |
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 18.19B |
| Revenue/Share | 200.63 |
| Gross Profit | 9.85B |
| EBITDA | 3.84B |
| Net Income | 1.75B |
| Diluted EPS | 19.25 |
Balance Sheet
| Total Cash | 96.16M |
| Total Cash/Share | 1.06 |
| Total Debt | 7.54B |
| Total Debt/Equity | 0.36 |
| Current Ratio | 1.49 |
| Book Value Per Share | 234.27 |
Price History
| 52-Week Change | -28.65 |
| 52-Week High | 971 |
| 52-Week Low | 585 |
| Moving Average 50 Days | 689.75 |
| Moving Average 200 Days | 755.85 |
Statistics
| Average Volume | 213,886 |
| Shares Outstanding | 90.66M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 0.63 |
| Payout Ratio | 0.12 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
